SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
SIGA Technologies Inc (SIGA) - Net Assets
Latest net assets as of September 2025: $203.48 Million USD
Based on the latest financial reports, SIGA Technologies Inc (SIGA) has net assets worth $203.48 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($231.60 Million) and total liabilities ($28.12 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $203.48 Million |
| % of Total Assets | 87.86% |
| Annual Growth Rate | 25.19% |
| 5-Year Change | 66.27% |
| 10-Year Change | N/A |
| Growth Volatility | 621.43 |
SIGA Technologies Inc - Net Assets Trend (1996–2024)
This chart illustrates how SIGA Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SIGA Technologies Inc (1996–2024)
The table below shows the annual net assets of SIGA Technologies Inc from 1996 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $215.80 Million | +9.62% |
| 2023-12-31 | $196.86 Million | +15.69% |
| 2022-12-31 | $170.16 Million | -2.38% |
| 2021-12-31 | $174.31 Million | +34.30% |
| 2020-12-31 | $129.79 Million | +32.74% |
| 2019-12-31 | $97.78 Million | -4.99% |
| 2018-12-31 | $102.91 Million | +131.85% |
| 2017-12-31 | $-323.14 Million | -12.43% |
| 2016-12-31 | $-287.42 Million | -1.05% |
| 2015-12-31 | $-284.43 Million | -15.39% |
| 2014-12-31 | $-246.50 Million | -1552.11% |
| 2013-12-31 | $16.98 Million | -41.36% |
| 2012-12-31 | $28.95 Million | -30.56% |
| 2011-12-31 | $41.69 Million | +245.40% |
| 2010-12-31 | $12.07 Million | +15.07% |
| 2009-12-31 | $10.49 Million | +574.68% |
| 2008-12-31 | $1.55 Million | -70.27% |
| 2007-12-31 | $5.23 Million | -28.20% |
| 2006-12-31 | $7.28 Million | +125.37% |
| 2005-12-31 | $3.23 Million | -29.13% |
| 2004-12-31 | $4.56 Million | -17.87% |
| 2003-12-31 | $5.55 Million | +155.46% |
| 2002-12-31 | $2.17 Million | -38.64% |
| 2001-12-31 | $3.54 Million | +282.97% |
| 2000-12-31 | $924.74K | -57.97% |
| 1999-12-31 | $2.20 Million | -60.71% |
| 1998-12-31 | $5.60 Million | -47.17% |
| 1997-12-31 | $10.60 Million | +2550.00% |
| 1996-12-31 | $400.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to SIGA Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2053801200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.14K | 0.00% |
| Other Components | $238.64 Million | 110.58% |
| Total Equity | $215.80 Million | 100.00% |
SIGA Technologies Inc Competitors by Market Cap
The table below lists competitors of SIGA Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Changzhou Shenli Electrical Machine Incorporated Co
SHG:603819
|
$203.63 Million |
|
Shenzhen Friendcom Technology Development Co Ltd
SHE:300514
|
$203.64 Million |
|
Hung Sheng Construction Ltd
TW:2534
|
$203.67 Million |
|
Doktas Dokumculuk Ticaret ve Sanayi AS
IS:DOKTA
|
$203.74 Million |
|
Fidelity D&D Bancorp Inc
NASDAQ:FDBC
|
$203.55 Million |
|
Palisade Bio Inc
NASDAQ:PALI
|
$203.35 Million |
|
Alkane Resources Ltd
AU:ALK
|
$203.33 Million |
|
Civeo Corp
NYSE:CVEO
|
$203.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SIGA Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 196,858,907 to 215,804,763, a change of 18,945,856 (9.6%).
- Net income of 59,214,216 contributed positively to equity growth.
- Dividend payments of 42,665,044 reduced retained earnings.
- Other factors increased equity by 2,396,684.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $59.21 Million | +27.44% |
| Dividends Paid | $42.67 Million | -19.77% |
| Other Changes | $2.40 Million | +1.11% |
| Total Change | $- | 9.62% |
Book Value vs Market Value Analysis
This analysis compares SIGA Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.67x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 38.49x to 1.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-12-31 | $0.13 | $5.02 | x |
| 1997-12-31 | $2.73 | $5.02 | x |
| 1998-12-31 | $0.86 | $5.02 | x |
| 1999-12-31 | $0.33 | $5.02 | x |
| 2000-12-31 | $0.13 | $5.02 | x |
| 2001-12-31 | $0.42 | $5.02 | x |
| 2002-12-31 | $0.21 | $5.02 | x |
| 2003-12-31 | $0.35 | $5.02 | x |
| 2004-12-31 | $0.19 | $5.02 | x |
| 2005-12-31 | $0.13 | $5.02 | x |
| 2006-12-31 | $0.26 | $5.02 | x |
| 2007-12-31 | $0.16 | $5.02 | x |
| 2008-12-31 | $0.04 | $5.02 | x |
| 2009-12-31 | $0.28 | $5.02 | x |
| 2010-12-31 | $0.27 | $5.02 | x |
| 2011-12-31 | $0.77 | $5.02 | x |
| 2012-12-31 | $0.56 | $5.02 | x |
| 2013-12-31 | $0.32 | $5.02 | x |
| 2014-12-31 | $-4.61 | $5.02 | x |
| 2015-12-31 | $-5.29 | $5.02 | x |
| 2016-12-31 | $-5.03 | $5.02 | x |
| 2017-12-31 | $-4.10 | $5.02 | x |
| 2018-12-31 | $1.24 | $5.02 | x |
| 2019-12-31 | $1.19 | $5.02 | x |
| 2020-12-31 | $1.63 | $5.02 | x |
| 2021-12-31 | $2.28 | $5.02 | x |
| 2022-12-31 | $2.31 | $5.02 | x |
| 2023-12-31 | $2.75 | $5.02 | x |
| 2024-12-31 | $3.01 | $5.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SIGA Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 27.44%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 42.69%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 1.13x
- Recent ROE (27.44%) is above the historical average (-106.87%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | -575.00% | -2300.00% | 0.17x | 1.50x | $-2.34 Million |
| 1997 | -20.75% | -314.29% | 0.06x | 1.05x | $-3.26 Million |
| 1998 | -117.86% | -1320.00% | 0.07x | 1.27x | $-7.16 Million |
| 1999 | -163.64% | -720.00% | 0.15x | 1.55x | $-3.82 Million |
| 2000 | -842.36% | -1612.35% | 0.15x | 3.47x | $-7.88 Million |
| 2001 | -105.31% | -321.66% | 0.28x | 1.19x | $-4.08 Million |
| 2002 | -153.29% | -967.06% | 0.12x | 1.30x | $-3.55 Million |
| 2003 | -95.05% | -721.11% | 0.12x | 1.10x | $-5.83 Million |
| 2004 | -205.58% | -509.65% | 0.30x | 1.34x | $-9.83 Million |
| 2005 | -70.80% | -26.99% | 1.39x | 1.89x | $-2.61 Million |
| 2006 | -135.94% | -136.39% | 0.52x | 1.93x | $-10.63 Million |
| 2007 | -107.85% | -84.17% | 0.63x | 2.03x | $-6.16 Million |
| 2008 | -553.16% | -106.62% | 0.92x | 5.66x | $-8.75 Million |
| 2009 | -167.97% | -127.56% | 0.53x | 2.47x | $-18.67 Million |
| 2010 | -233.62% | -146.73% | 0.71x | 2.24x | $-29.40 Million |
| 2011 | 32.61% | 106.82% | 0.14x | 2.17x | $9.43 Million |
| 2012 | -50.19% | -161.95% | 0.08x | 3.66x | $-17.42 Million |
| 2013 | -101.19% | -311.22% | 0.03x | 11.42x | $-18.87 Million |
| 2014 | 0.00% | -8454.68% | 0.02x | 0.00x | $-240.81 Million |
| 2015 | 0.00% | -482.53% | 0.04x | 0.00x | $-11.01 Million |
| 2016 | 0.00% | -264.87% | 0.09x | 0.00x | $-10.96 Million |
| 2017 | 0.00% | -295.34% | 0.08x | 0.00x | $-3.92 Million |
| 2018 | 409.86% | 88.42% | 2.34x | 1.98x | $411.52 Million |
| 2019 | -7.41% | -27.08% | 0.13x | 2.03x | $-17.02 Million |
| 2020 | 43.41% | 45.09% | 0.83x | 1.15x | $43.36 Million |
| 2021 | 39.84% | 51.96% | 0.62x | 1.23x | $52.02 Million |
| 2022 | 19.93% | 30.61% | 0.57x | 1.15x | $16.89 Million |
| 2023 | 34.58% | 48.65% | 0.55x | 1.29x | $48.38 Million |
| 2024 | 27.44% | 42.69% | 0.57x | 1.13x | $37.63 Million |
Industry Comparison
This section compares SIGA Technologies Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SIGA Technologies Inc (SIGA) | $203.48 Million | -575.00% | 0.14x | $203.61 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |